Estimation of CYP3A4*1B single nucleotide polymorphism in patients with recurrent Major Depressive Disorder.

Rafał ŚwiechowskiAgnieszka JeleńMarek MirowskiMonika TalarowskaPiotr GałeckiJacek PietrzakDamian WodzińskiEwa Balcerczak

Published in: Molecular genetics & genomic medicine (2019)

The study suggests that CYP3A4*1B polymorphism have no influence on the predisposition to depression, the severity of depressive symptoms and the efficiency of antidepressant therapy.

Keyphrases

major depressive disorder
depressive symptoms
bipolar disorder
sleep quality
social support
stem cells
cell therapy